You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 11, 2024

CLINICAL TRIALS PROFILE FOR EPIPEN JR.


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for EPIPEN JR.

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00434421 ↗ Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed Inner-City Asthma Consortium Phase 1 2007-02-01 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00434421 ↗ Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 1 2007-02-01 Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance and adverse events with subcutaneous allergen immunotherapy have generated interest in delivering immunotherapy sublingually (under the tongue). The purpose of this study is to evaluate the safety of a cockroach extract given sublingually to people with perennial (year-round) allergic rhinitis, with or without asthma.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Medical University of South Carolina Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed University of California, San Francisco Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT00809146 ↗ Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Completed Robert Silbergleit Phase 3 2009-06-01 The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
NCT01432522 ↗ A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine Completed Mahidol University N/A 2010-07-01 This study is a preliminary report of pharmacokinetic data of epinephrine administered via intranasal route (IN) comparing with intramuscular (IM) route in healthy adult volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for EPIPEN JR.

Condition Name

Condition Name for EPIPEN JR.
Intervention Trials
Anaphylaxis 2
Urticaria Chronic 1
Multiple Sclerosis 1
Venomous Snakebites 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for EPIPEN JR.
Intervention Trials
Rhinitis, Allergic 2
Rhinitis 2
Anaphylaxis 2
Brain Edema 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for EPIPEN JR.

Trials by Country

Trials by Country for EPIPEN JR.
Location Trials
United States 40
Thailand 1
Hungary 1
Canada 1
Croatia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for EPIPEN JR.
Location Trials
Maryland 4
New York 3
Wisconsin 2
Virginia 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for EPIPEN JR.

Clinical Trial Phase

Clinical Trial Phase for EPIPEN JR.
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2/Phase 3 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for EPIPEN JR.
Clinical Trial Phase Trials
Completed 8
Unknown status 1
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EPIPEN JR.

Sponsor Name

Sponsor Name for EPIPEN JR.
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 2
Mahidol University 1
Siriraj Hospital 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for EPIPEN JR.
Sponsor Trials
Other 10
Industry 5
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.